Owen N. Witte, Director at Kite Pharma, Inc. (KITE), sold 25,000 shares at $100.60 ($2.5M) on 2017-06-26, disclosed to the SEC on 2017-06-26.
Open-market sale of $2.5M KITE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.00 | 12,500 | $1.3M | 49.9% |
| 2 | $100.60 | 12,500 | $1.3M | 50.1% |
| Total | $100.30 avg | 25,000 | $2.5M | 100% |
| Filing → |
| ALLO | SELL | 2021-09-09 | $128K | — | Filing → |
| ALLO | SELL | 2021-08-23 | $351K | — | Filing → |
| ALLO | SELL | 2021-06-11 | $499K | — | Filing → |